Red Light Therapy 101

How Does Red Light Therapy Work?

Red light therapy — also called photobiomodulation (PBM) or low-level light therapy (LLLT) — uses specific wavelengths of red and near-infrared light to support cellular energy production via mitochondrial pathways. Here is what the science says, what the clinical evidence shows, and how to use it effectively.

Direct answer

What is red light therapy? Red light therapy (photobiomodulation or PBM) is a non-invasive modality that uses wavelengths between 600–1000nm to support cellular energy production via mitochondrial pathways. Red and near-infrared photons are absorbed by cytochrome c oxidase — a key enzyme in the mitochondrial electron transport chain — increasing ATP synthesis and triggering downstream effects on inflammation, tissue repair, and cellular function. Across 10,000+ peer-reviewed studies, the 808–810nm band is the most studied (1,205 studies combined), followed by 630–633nm (989 combined), 660nm (943), and 830nm (624).

Scientific Advisor
Dr. Alexis Cowan, PhD

Princeton-trained molecular biologist specialising in metabolism and cellular energy systems. Dr. Cowan advises Mito Red Light on the science of photobiomodulation and mitochondrial health.

10,000+ Peer-reviewed studies on photobiomodulation
630–633nm Most studied red wavelength band (989 studies) — per our database of 10,000+ studies
808–810nm Most studied near-infrared band (1,205 studies) — per our database of 10,000+ studies
1967 First published PBM research (Mester et al., PMID: 5582729)
The mechanism

The cellular science behind red light therapy

Direct answer

Does red light therapy increase ATP? Yes — research indicates that red and near-infrared light increases mitochondrial ATP production by interacting with cytochrome c oxidase (complex IV of the electron transport chain), improving its efficiency and downstream energy output. This is the primary accepted mechanism of photobiomodulation. (Hamblin MR, AIMS Biophys. 2017; PMID: 28748217)

The best-studied mechanism of red and near-infrared light therapy is the stimulation of mitochondrial energy production. Mitochondria — organelles found in virtually every cell type in the human body — contain a photoreceptor enzyme called cytochrome c oxidase (complex IV) that absorbs specific red and near-infrared wavelengths.

When cytochrome c oxidase absorbs these photons, it increases the efficiency of the electron transport chain — the metabolic pathway that synthesises ATP (adenosine triphosphate), the body's primary energy currency. A 2017 review by Michael Hamblin at Harvard Medical School identified this as the central photoacceptor mechanism and described downstream effects including improved blood flow, modulation of reactive oxygen species, and changes in gene expression.

Light penetrates tissue

Red (630-660nm) and near-infrared (810-850nm) photons pass through skin and superficial tissue. NIR wavelengths penetrate several centimetres deeper than red light, reaching muscles, joints, and deeper structures.

Cytochrome c oxidase absorbs the photons

This key enzyme in the mitochondrial electron transport chain acts as the primary photoreceptor, converting light energy into biochemical energy. Wavelengths between 600–700nm and 760–940nm most closely match its absorption spectrum.

ATP production increases

The electron transport chain runs with improved efficiency, producing more ATP — the molecule that powers every cellular function, from muscle contraction to immune response to collagen synthesis.

Downstream effects follow

Downstream effects include improved blood flow, changes in inflammation markers and oxidative stress, and altered gene expression — driving the diverse clinical benefits observed across different tissue types.

Why the applications are so broad

Every cell in the human body — except red blood cells — contains mitochondria. A 2026 Nature feature noted that mitochondria "are emerging as a central piece of the puzzle" explaining photobiomodulation's wide-ranging effects. Because PBM acts at the level of mitochondrial function, research has explored its effects across virtually every tissue type: skin, muscle, nerve, bone, and more. (Nature, 2026)

Mito Red Light devices deliver multiple clinically validated wavelengths — 590nm, 630nm, 660nm, and 670nm in the red range; 810nm, 830nm, 850nm, and 940nm in near-infrared. The MitoPRO+ (4 wavelengths), MitoPRO X (6 wavelengths), and MitoADAPT 4.0 (8 wavelengths) are engineered to hit therapeutic dose in a standard session.

See devices →
Wavelengths

Red light vs near-infrared light: what is the difference?

Not all wavelengths produce equal biological effects. The two ranges with the strongest clinical evidence are red light (600–700nm) and near-infrared light (700–1100nm). Both stimulate the same mitochondrial mechanism but differ fundamentally in depth of tissue penetration.

● Red light · 590–700nm

Skin & surface tissue

Visible to the human eye. Primarily acts on skin, superficial tissue, and hair follicles. Best studied for collagen production, wrinkle reduction, wound healing, and hair follicle stimulation. Mito Red Light devices use 630nm, 660nm, and 670nm across the product range — wavelengths closely matched to the peak absorption spectrum of cytochrome c oxidase in skin tissue. The MitoADAPT also includes 590nm, studied for superficial skin and mood applications.

● Near-infrared · 810–940nm

Deep tissue & systemic effects

Invisible to the human eye. Penetrates several centimetres into the body, reaching muscles, joints, tendons, and bone. Best studied for muscle recovery, joint health, and neurological applications. The 808–810nm band is the single most studied wavelength group in photobiomodulation research (1,205 studies combined), followed by 830nm (624 studies). Mito Red Light devices use 810nm, 830nm, and 850nm across the range. The MitoADAPT additionally includes 940nm, the deepest-penetrating wavelength in the lineup.

Feature Red light (660nm) Near-infrared (850nm)
Visibility Visible (red/amber glow) Invisible to the eye
Wavelength range 590–700nm 810–940nm
Penetration depth ~1–3mm (skin surface) ~3–5cm+ (deep tissue)
Primary target Skin, epidermis, hair follicles Muscle, joints, tendons, bone
Best studied for Collagen, wrinkles, wound healing, hair growth Muscle recovery, joint pain, neuroprotection
Cytochrome c oxidase absorption High (peak ~630–670nm) High (peak ~800–830nm)
MitoPRO+ 630nm, 660nm 830nm, 850nm
MitoPRO X 590nm, 630nm, 660nm 810nm, 830nm, 850nm
MitoADAPT 590nm, 630nm, 660nm, 670nm 810nm, 830nm, 850nm, 940nm

The range between approximately 600–1000nm is known as the optical window (or therapeutic window) — the zone where light achieves maximum depth of tissue penetration before blood absorption (below 600nm) or water absorption (above 1000nm) limits effectiveness. All Mito Red Light panels operate within this validated window.

Deep dive Complete wavelength guide: 660nm vs 850nm — what the research says →
Clinical evidence

What is red light therapy used for?

A 2025 consensus review in the Journal of the American Academy of Dermatology, co-authored by more than 20 specialists, concluded that photobiomodulation therapy (PBMT) is safe and effective for several types of ulcer, peripheral neuropathy, acute radiation dermatitis, and androgenic alopecia. The FDA approved a red-light device for dry age-related macular degeneration in 2024, and red-light therapy has been included in clinical guidelines for oral mucositis prevention since 2020. (Maghfour et al., J Am Acad Dermatol. 2025; PMID: in press)

Skin health & anti-aging

Stimulates collagen and elastin synthesis. Multiple RCTs show reductions in wrinkle depth, improved skin tone, and accelerated wound healing. FDA-cleared devices available in this category.

Muscle recovery

Reduces delayed onset muscle soreness (DOMS). A 2025 meta-analysis in Sports Health confirmed pre-exercise PBM improves muscle performance and recovery. (Qiu et al., 2025)

Hair growth

Stimulates follicular activity in androgenetic alopecia. Included in the 2025 specialist consensus review as an effective application. FDA-cleared LED devices exist in this category.

Inflammation & pain

Modulates pro-inflammatory cytokines and prostaglandins. Clinical trials show reductions in pain for osteoarthritis and fibromyalgia. (González-Muñoz et al., Healthcare. 2023)

Brain & neurological health

Transcranial PBM studies show promise for cognition, mood, and neuroprotection. Animal models of Parkinson's disease show preservation of dopamine-producing neurons. Multiple human trials underway.

Metabolic health

Early clinical evidence for effects on body composition and metabolic function. A 2024 study in Frontiers in Endocrinology examined PBM effects on metabolic disease markers. (Perrier et al., 2024)

The MitoGLOW LED face mask targets skin health and collagen. The MitoPRO panel series addresses muscle recovery, inflammation, and systemic applications.

Explore devices →
Research Red light therapy & inflammation: full evidence guide → Research Red light therapy & skin: collagen, wrinkles, wound healing → Research Red light therapy & muscle recovery: the evidence → Research Red light therapy & hair growth: protocols & studies →
Full evidence library Research Evidence Hub: browse 10,000+ peer-reviewed studies →
Context

The modern indoor light environment and reduced spectral exposure

Human biology evolved under full-spectrum natural sunlight, which includes substantial red and near-infrared wavelengths throughout the day. Research on the biological effects of light exposure — including its roles in circadian regulation, retinal health, and metabolic function — has highlighted the extent to which the modern built environment has narrowed the spectrum of light humans receive.

Three converging factors have reduced exposure to red and near-infrared wavelengths in modern populations:

Indoor time: People in developed nations now spend the majority of their time indoors. Studies on light exposure and circadian health — including work by the Heschong Mahone Group and research cited in circadian biology literature — have examined the downstream consequences of reduced natural light access. (Heschong et al., J. Illum. Eng. Soc. 2013)

Spectral narrowing of artificial lighting: The transition to energy-efficient LED and CFL lighting has produced indoor environments rich in blue-spectrum light but largely devoid of red and near-infrared wavelengths — wavelengths that were present in incandescent lighting and natural sunlight. A 2026 Nature feature on photobiomodulation explicitly noted that "efforts to conserve energy have narrowed the spectrum of indoor lighting, eliminating many red and near-infrared wavelengths." (Nature, 2026: Peeples L.)

Window filtration: Modern energy-efficient windows in buildings and vehicles are designed to block infrared transmission, further attenuating exposure to these wavelengths even when near natural light sources.

Scientific context

The phrase "red-light deficiency" is not established clinical terminology. The more precise framing — used in photobiomodulation research — is reduced exposure to the red and near-infrared portions of the natural light spectrum. The biological relevance of this reduction is an active area of scientific inquiry, distinct from established deficiency concepts like vitamin D. Researchers quoted in Nature (2026) describe the phenomenon as humans being "literally starved of something that, biologically, we've evolved to receive" — though this remains a hypothesis under investigation rather than a confirmed clinical syndrome.

Safety

Is red light therapy safe?

Red light therapy at therapeutic wavelengths and power densities has an excellent safety record across thousands of published clinical studies spanning over 50 years. It is non-ionising — unlike UV, X-ray, or gamma radiation, it carries no ionising energy and has no known mechanism for DNA damage. The 2025 specialist consensus review explicitly concluded that photobiomodulation therapy is safe for its reviewed indications.

Safety consensus

No serious adverse effects have been reported at therapeutic doses in the peer-reviewed literature. The primary safety precaution is retinal protection — eye protection should always be worn during treatment, as direct exposure to high-irradiance LEDs carries potential risk regardless of wavelength. (Maghfour et al., J Am Acad Dermatol. 2025)

Populations who should consult a physician before use: people taking photosensitising medications, individuals with active cancers in the treatment area, pregnant women (insufficient safety data), those with epilepsy or light-triggered conditions, and anyone with recent surgery in the target tissue.

Safety guide Full contraindications guide: who should not use red light therapy →
Common questions

Frequently asked questions about red light therapy

Yes — for the most-studied applications, the evidence is substantial. Over 10,000 peer-reviewed studies have examined photobiomodulation. A 2025 consensus review in the Journal of the American Academy of Dermatology (Maghfour et al.) concluded PBMT is safe and effective for peripheral neuropathy, several types of ulcer, acute radiation dermatitis, and androgenic alopecia. The FDA has approved PBM devices for dry age-related macular degeneration. The underlying mechanism — cytochrome c oxidase absorbing red/NIR photons to increase mitochondrial ATP production — is well-established in cellular biophysics. (Hamblin, AIMS Biophys. 2017; PMID: 28748217)

Key reference: Hamblin MR. "Mechanisms and applications of the anti-inflammatory effects of photobiomodulation." AIMS Biophys. 2017;4(3):337–361.

Timeline varies by application. Muscle recovery: improvements often measurable within 1–3 sessions, consistent with acute anti-inflammatory and ATP effects. Skin (collagen, wrinkles): clinical trials consistently show measurable changes at 8–12 weeks with regular use. Hair growth: the 2025 consensus review referenced studies running 16–24 weeks. Red light therapy works through cumulative biological adaptation — not acute drug-like effects. Consistency over weeks produces the best outcomes.

Red light (600–700nm) and near-infrared light (700–1100nm) both operate via a photochemical (non-thermal) mechanism — photon absorption by cytochrome c oxidase driving mitochondrial ATP production. Far-infrared (3,000nm+), used in infrared saunas, works via a thermal mechanism generating heat. These are fundamentally different biological pathways. Quality photobiomodulation devices such as the Mito Red Light MitoPRO and MitoADAPT panels include both red (660nm) and near-infrared (850nm) LEDs to address both surface and deep-tissue targets.

Distance depends on a device's irradiance (power density at the treatment surface, measured in mW/cm²). Most full-size LED panels are used at 6–24 inches (15–60cm). The therapeutic target is typically 10–60 J/cm² energy dose depending on the application. Higher-irradiance devices can be used at greater distance and still deliver a sufficient dose in a short session. Mito Red Light panels include irradiance charts and dosing guides for each device.

Daily use is generally safe and is used in many published clinical protocols. Research suggests 3–5 sessions per week is optimal for most applications, consistent with the biphasic dose-response observed in PBM research — where both too little and too much light can reduce effectiveness. Standard recommendation: 5–15 minutes per treatment area, once daily, most days of the week.

The five factors that matter: (1) Wavelengths — look for 660nm and/or 850nm — the most extensively studied wavelengths. 630nm and 633nm are also well-researched red wavelengths with strong skin evidence. Near-infrared options include 810nm, 830nm, and 850nm; (2) Irradiance in mW/cm² at treatment distance — not just total wattage, which tells you nothing about dose; (3) Coverage area for your intended use case; (4) Low EMF output; (5) Third-party verified specifications. Red light therapy devices like the MitoPRO and MitoADAPT panels publish irradiance data verified by independent labs. Be cautious of devices that only list wattage without irradiance figures.

Continue learning

Explore further

Evidence hub Research Evidence Hub: 10,000+ studies by topic Interactive tool Evidence Explorer: searchable studies database Wavelengths guide 660nm vs 850nm: complete breakdown Safety Contraindications: who should not use red light therapy Shop Browse all red light therapy panels — MitoPRO+, MitoPRO X, MitoADAPT Beginner guide What is red light therapy? Full introduction